Details for: SDCBP

Gene ID: 6386

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: SDCBP

Ensembl ID: ENSG00000137575

Description: syndecan binding protein

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • melanocyte CL0000148
    CSI 127.07
    rCSI 94.11%
    PRS 13.75
  • elicited macrophage CL0000861
    CSI 102.61
    rCSI 94.21%
    PRS 18.05
  • extravillous trophoblast CL0008036
    CSI 66.78
    rCSI 82.62%
    PRS 13.67
  • myeloid leukocyte CL0000766
    CSI 64.27
    rCSI 59.3%
    PRS 15.97
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 63.5
    rCSI 48.93%
    PRS 14.29
  • Hofbauer cell CL3000001
    CSI 54.49
    rCSI 100%
    PRS 19.54
  • intermediate monocyte CL0002393
    CSI 51.52
    rCSI 77.73%
    PRS 15.56
  • alveolar macrophage CL0000583
    CSI 50.68
    rCSI 83.48%
    PRS 18.34
  • alternatively activated macrophage CL0000890
    CSI 50.37
    rCSI 63.32%
    PRS 23.93
  • skin fibroblast CL0002620
    CSI 45.33
    rCSI 39.08%
    PRS 24.97
  • placental villous trophoblast CL2000060
    CSI 45.25
    rCSI 69.92%
    PRS 14.59
  • classical monocyte CL0000860
    CSI 43.34
    rCSI 64.25%
    PRS 77.3
  • retinal blood vessel endothelial cell CL0002585
    CSI 41.76
    rCSI 66.69%
    PRS 17.12
  • mucous neck cell CL0000651
    CSI 37.33
    rCSI 53.8%
    PRS 24.91
  • macrophage CL0000235
    CSI 36.81
    rCSI 66.97%
    PRS 55.73
  • pulmonary artery endothelial cell CL1001568
    CSI 33.15
    rCSI 45.11%
    PRS 23.75
  • retinal pigment epithelial cell CL0002586
    CSI 32.74
    rCSI 65.01%
    PRS 16.59
  • foveolar cell of stomach CL0002179
    CSI 30.48
    rCSI 64.87%
    PRS 25.05
  • pancreatic acinar cell CL0002064
    CSI 29.63
    rCSI 39.38%
    PRS 17.09
  • lung macrophage CL1001603
    CSI 27.11
    rCSI 60.56%
    PRS 17.89
  • endothelial cell of artery CL1000413
    CSI 26.96
    rCSI 39.5%
    PRS 63.36
  • syncytiotrophoblast cell CL0000525
    CSI 26.52
    rCSI 76.4%
    PRS 29.79
  • monocyte CL0000576
    CSI 26.26
    rCSI 47.47%
    PRS 41.08
  • basophil CL0000767
    CSI 25.29
    rCSI 53.5%
    PRS 31.32
  • forebrain radial glial cell CL0013000
    CSI 24.32
    rCSI 78.03%
    PRS 22.64
  • granulocyte CL0000094
    CSI 24.17
    rCSI 36.93%
    PRS 19.88
  • non-classical monocyte CL0000875
    CSI 23.46
    rCSI 37.6%
    PRS 45.51
  • lung endothelial cell CL1001567
    CSI 22.76
    rCSI 53.07%
    PRS 36.42
  • blood vessel endothelial cell CL0000071
    CSI 22.36
    rCSI 46.4%
    PRS 15.61
  • pancreatic ductal cell CL0002079
    CSI 22
    rCSI 42.78%
    PRS 15.99
  • keratocyte CL0002363
    CSI 21.15
    rCSI 50.85%
    PRS 23.25
  • lung interstitial macrophage CL4033043
    CSI 21.04
    rCSI 47.24%
    PRS 31.86
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 20.5
    rCSI 26.87%
    PRS 22.02
  • Kupffer cell CL0000091
    CSI 20.25
    rCSI 46.31%
    PRS 15.08
  • conjunctival epithelial cell CL1000432
    CSI 19.8
    rCSI 30.25%
    PRS 15.67
  • endothelial cell of lymphatic vessel CL0002138
    CSI 19.4
    rCSI 38.45%
    PRS 44.2
  • endothelial cell of placenta CL0009092
    CSI 19.06
    rCSI 93.96%
    PRS 21.17
  • promonocyte CL0000559
    CSI 18.18
    rCSI 31.15%
    PRS 21.13
  • mononuclear phagocyte CL0000113
    CSI 17.12
    rCSI 37.69%
    PRS 17.42
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 16.87
    rCSI 20.38%
    PRS 18.51
  • vein endothelial cell CL0002543
    CSI 16.69
    rCSI 45.55%
    PRS 55.31
  • basal cell of prostate epithelium CL0002341
    CSI 16.32
    rCSI 47.21%
    PRS 34.12
  • vasa recta ascending limb cell CL1001131
    CSI 16.28
    rCSI 73.65%
    PRS 51.61
  • ciliated epithelial cell CL0000067
    CSI 16.21
    rCSI 14.25%
    PRS 11.33
  • colon macrophage CL0009038
    CSI 15.3
    rCSI 70.69%
    PRS 32.35
  • small intestine goblet cell CL1000495
    CSI 15.21
    rCSI 33.31%
    PRS 20.85
  • cerebral cortex endothelial cell CL1001602
    CSI 15.15
    rCSI 26.21%
    PRS 11.86
  • epithelial cell of lung CL0000082
    CSI 14.97
    rCSI 12.41%
    PRS 14.72
  • alveolar adventitial fibroblast CL4028006
    CSI 14.66
    rCSI 23.16%
    PRS 15.63
  • vein endothelial cell of respiratory system CL4033008
    CSI 14.53
    rCSI 99.76%
    PRS 30.39
  • keratinocyte CL0000312
    CSI 13.92
    rCSI 11.67%
    PRS 18.67
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 13.84
    rCSI 83.71%
    PRS 34.66
  • natural T-regulatory cell CL0000903
    CSI 13.82
    rCSI 26.17%
    PRS 41.8
  • tissue-resident macrophage CL0000864
    CSI 13.73
    rCSI 64.24%
    PRS 31.7
  • stem cell CL0000034
    CSI 13.68
    rCSI 13.19%
    PRS 11.07
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 12.78
    rCSI 11.54%
    PRS 13.94
  • microcirculation associated smooth muscle cell CL0008035
    CSI 12.71
    rCSI 36.8%
    PRS 17.7
  • CD14-positive monocyte CL0001054
    CSI 12.45
    rCSI 15.51%
    PRS 22.05
  • myeloid cell CL0000763
    CSI 12.41
    rCSI 51.11%
    PRS 45.3
  • capillary endothelial cell CL0002144
    CSI 11.63
    rCSI 21.31%
    PRS 54.94
  • mammary gland epithelial cell CL0002327
    CSI 11.42
    rCSI 40.06%
    PRS 27.88
  • Langerhans cell CL0000453
    CSI 11.4
    rCSI 17.41%
    PRS 27.38
  • tracheobronchial serous cell CL0019001
    CSI 11.37
    rCSI 49.13%
    PRS 29.25
  • endothelial cell of uterus CL0009095
    CSI 11.13
    rCSI 81.34%
    PRS 41.53
  • mesodermal cell CL0000222
    CSI 11.09
    rCSI 13.31%
    PRS 15.37
  • pancreatic stellate cell CL0002410
    CSI 10.79
    rCSI 62.76%
    PRS 23.41
  • pancreatic A cell CL0000171
    CSI 10.5
    rCSI 11%
    PRS 16.68
  • adventitial cell CL0002503
    CSI 10.43
    rCSI 24.91%
    PRS 24
  • glioblast CL0000030
    CSI 10.3
    rCSI 16.43%
    PRS 13.41
  • vasa recta descending limb cell CL1001285
    CSI 10.12
    rCSI 80.79%
    PRS 57.12
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 9.82
    rCSI 9.07%
    PRS 28.27
  • conventional dendritic cell CL0000990
    CSI 9.54
    rCSI 7.97%
    PRS 43.31
  • enteric smooth muscle cell CL0002504
    CSI 9.18
    rCSI 13.1%
    PRS 17.6
  • fallopian tube secretory epithelial cell CL4030006
    CSI 8.77
    rCSI 8.44%
    PRS 16.17
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 8.5
    rCSI 14.54%
    PRS 31.17
  • endothelial cell of venule CL1000414
    CSI 8.44
    rCSI 74.86%
    PRS 55.09
  • enterocyte CL0000584
    CSI 8.43
    rCSI 13.59%
    PRS 24.6
  • myeloid dendritic cell CL0000782
    CSI 8.39
    rCSI 12.16%
    PRS 23.22
  • bronchial goblet cell CL1000312
    CSI 8.08
    rCSI 32.28%
    PRS 33.43
  • neutrophil CL0000775
    CSI 7.95
    rCSI 44.46%
    PRS 30.17
  • radial glial cell CL0000681
    CSI 7.56
    rCSI 10.51%
    PRS 16.04
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 7.53
    rCSI 81.88%
    PRS 55.65
  • Bergmann glial cell CL0000644
    CSI 7.06
    rCSI 9.66%
    PRS 15.57
  • naive T cell CL0000898
    CSI 7.04
    rCSI 4.9%
    PRS 22.16
  • respiratory suprabasal cell CL4033048
    CSI 6.97
    rCSI 8.94%
    PRS 18.03
  • stromal cell CL0000499
    CSI 6.96
    rCSI 19.59%
    PRS 21.65
  • endothelial cell of arteriole CL1000412
    CSI 6.66
    rCSI 36.94%
    PRS 43.13
  • T-helper 1 cell CL0000545
    CSI 6.65
    rCSI 12%
    PRS 40
  • unswitched memory B cell CL0000970
    CSI 6.61
    rCSI 5.56%
    PRS 24.95
  • stromal cell of ovary CL0002132
    CSI 6.54
    rCSI 17.97%
    PRS 25.75
  • acinar cell CL0000622
    CSI 6.4
    rCSI 9.38%
    PRS 20.51
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 6.24
    rCSI 12.44%
    PRS 26.25
  • myofibroblast cell CL0000186
    CSI 6.2
    rCSI 8.59%
    PRS 22.26
  • enterocyte of epithelium of large intestine CL0002071
    CSI 6.15
    rCSI 32.31%
    PRS 27.24
  • lung ciliated cell CL1000271
    CSI 6.14
    rCSI 7.1%
    PRS 11.43
  • mast cell CL0000097
    CSI 6.08
    rCSI 13.12%
    PRS 60.72
  • type B pancreatic cell CL0000169
    CSI 6.06
    rCSI 13.41%
    PRS 14.5
  • common dendritic progenitor CL0001029
    CSI 5.99
    rCSI 7.52%
    PRS 20.08
  • hepatic stellate cell CL0000632
    CSI 5.96
    rCSI 22.31%
    PRS 13.22
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 5.88
    rCSI 3.96%
    PRS 18.83
  • astrocyte of the cerebral cortex CL0002605
    CSI -5.1
    rCSI -11.4%
    PRS 9.6%
  • alpha-beta T cell CL0000789
    CSI -4.4
    rCSI -5.2%
    PRS 20.9%
  • renal alpha-intercalated cell CL0005011
    CSI -2.7
    rCSI -3.6%
    PRS 20.6%
  • neural cell CL0002319
    CSI -1.9
    rCSI -7.2%
    PRS 22.0%
  • platelet CL0000233
    CSI -1.8
    rCSI -7.5%
    PRS 30.7%
  • common lymphoid progenitor CL0000051
    CSI -1.8
    rCSI -2.4%
    PRS 29.7%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI -1.7
    rCSI -5.4%
    PRS 10.5%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI -1.7
    rCSI -3.1%
    PRS 12.8%
  • enteroendocrine cell of small intestine CL0009006
    CSI -1.1
    rCSI -2.5%
    PRS 23.8%
  • regular ventricular cardiac myocyte CL0002131
    CSI -0.8
    rCSI -5.3%
    PRS 12.2%
  • fibroblast of cardiac tissue CL0002548
    CSI -0.7
    rCSI -3.5%
    PRS 11.0%
  • neural progenitor cell CL0011020
    CSI -0.7
    rCSI -3.0%
    PRS 15.0%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI -0.7
    rCSI -2.4%
    PRS 8.6%
  • exhausted T cell CL0011025
    CSI -0.5
    rCSI -8.0%
    PRS 55.0%
  • kidney connecting tubule epithelial cell CL1000768
    CSI -0.4
    rCSI -1.0%
    PRS 11.8%
  • central nervous system neuron CL2000029
    CSI -0.3
    rCSI -2.1%
    PRS 8.4%
  • amacrine cell CL0000561
    CSI -0.2
    rCSI -0.5%
    PRS 12.0%
  • sncg GABAergic cortical interneuron CL4023015
    CSI -0.1
    rCSI -0.2%
    PRS 10.0%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.0
    rCSI 0.0%
    PRS 25.6%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.1
    rCSI 0.2%
    PRS 55.6%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.1
    rCSI 1.3%
    PRS 46.1%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.1
    rCSI 0.4%
    PRS 9.4%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.1
    rCSI 0.3%
    PRS 9.8%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.1
    rCSI 0.6%
    PRS 50.5%
  • Cajal-Retzius cell CL0000695
    CSI 0.1
    rCSI 1.0%
    PRS 32.5%
  • B-2 B cell CL0000822
    CSI 0.1
    rCSI 2.8%
    PRS 68.2%
  • B-1 B cell CL0000819
    CSI 0.1
    rCSI 3.4%
    PRS 64.0%
  • retina horizontal cell CL0000745
    CSI 0.1
    rCSI 0.2%
    PRS 14.5%
  • medium spiny neuron CL1001474
    CSI 0.2
    rCSI 1.3%
    PRS 6.1%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 1.0%
    PRS 22.8%
  • hair follicular keratinocyte CL2000092
    CSI 0.2
    rCSI 3.0%
    PRS 56.9%
  • small pre-B-II cell CL0000954
    CSI 0.2
    rCSI 0.2%
    PRS 32.0%
  • odontoblast CL0000060
    CSI 0.2
    rCSI 5.5%
    PRS 60.5%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 0.3
    rCSI 1.4%
    PRS 9.7%
  • paneth cell of colon CL0009009
    CSI 0.3
    rCSI 3.1%
    PRS 42.3%
  • pancreatic epsilon cell CL0005019
    CSI 0.3
    rCSI 1.5%
    PRS 36.0%
  • neuroendocrine cell CL0000165
    CSI 0.3
    rCSI 1.2%
    PRS 31.4%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 0.3
    rCSI 0.6%
    PRS 9.2%
  • mesenchymal lymphangioblast CL0005021
    CSI 0.4
    rCSI 9.2%
    PRS 62.0%
  • mature B cell CL0000785
    CSI 0.4
    rCSI 0.3%
    PRS 19.4%
  • large pre-B-II cell CL0000957
    CSI 0.4
    rCSI 1.1%
    PRS 26.8%
  • parietal epithelial cell CL1000452
    CSI 0.4
    rCSI 1.1%
    PRS 12.9%
  • kidney resident macrophage CL1000698
    CSI 0.4
    rCSI 7.9%
    PRS 83.1%
  • renal principal cell CL0005009
    CSI 0.4
    rCSI 1.1%
    PRS 20.4%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.4
    rCSI 2.3%
    PRS 30.4%
  • periportal region hepatocyte CL0019026
    CSI 0.4
    rCSI 1.7%
    PRS 21.6%
  • retinal cone cell CL0000573
    CSI 0.5
    rCSI 0.7%
    PRS 12.0%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 0.5
    rCSI 5.2%
    PRS 21.1%
  • transit amplifying cell CL0009010
    CSI 0.5
    rCSI 0.8%
    PRS 25.4%
  • podocyte CL0000653
    CSI 0.5
    rCSI 2.4%
    PRS 15.3%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.5
    rCSI 0.7%
    PRS 20.1%
  • late pro-B cell CL0002048
    CSI 0.6
    rCSI 1.4%
    PRS 43.7%
  • serous secreting cell of bronchus submucosal gland CL4033005
    CSI 0.6
    rCSI 3.3%
    PRS 52.4%
  • intestinal tuft cell CL0019032
    CSI 0.6
    rCSI 0.9%
    PRS 17.9%
  • tracheal goblet cell CL1000329
    CSI 0.6
    rCSI 1.3%
    PRS 31.0%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.7
    rCSI 3.3%
    PRS 20.5%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 0.7
    rCSI 1.7%
    PRS 39.8%
  • erythroblast CL0000765
    CSI 0.7
    rCSI 1.8%
    PRS 25.4%
  • thymocyte CL0000893
    CSI 0.7
    rCSI 2.5%
    PRS 47.6%
  • sst GABAergic cortical interneuron CL4023017
    CSI 0.7
    rCSI 0.9%
    PRS 9.7%
  • uterine smooth muscle cell CL0002601
    CSI 0.7
    rCSI 4.6%
    PRS 69.3%
  • renal interstitial pericyte CL1001318
    CSI 0.7
    rCSI 2.0%
    PRS 14.5%
  • transitional stage B cell CL0000818
    CSI 0.8
    rCSI 2.6%
    PRS 41.9%
  • intraepithelial lymphocyte CL0002496
    CSI 0.8
    rCSI 2.2%
    PRS 56.8%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 0.8
    rCSI 1.1%
    PRS 31.8%
  • regular atrial cardiac myocyte CL0002129
    CSI 0.8
    rCSI 2.6%
    PRS 16.5%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.8
    rCSI 2.0%
    PRS 9.0%
  • glandular epithelial cell CL0000150
    CSI 0.8
    rCSI 2.2%
    PRS 30.4%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 0.8
    rCSI 3.7%
    PRS 51.8%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 0.9
    rCSI 0.5%
    PRS 21.6%
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 0.9
    rCSI 1.0%
    PRS 13.7%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.9
    rCSI 2.1%
    PRS 24.8%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 0.9
    rCSI 0.9%
    PRS 24.5%
  • fraction A pre-pro B cell CL0002045
    CSI 0.9
    rCSI 1.0%
    PRS 31.8%
  • intrahepatic cholangiocyte CL0002538
    CSI 0.9
    rCSI 2.2%
    PRS 28.0%
  • centrilobular region hepatocyte CL0019029
    CSI 0.9
    rCSI 2.4%
    PRS 24.3%
  • transit amplifying cell of small intestine CL0009012
    CSI 0.9
    rCSI 4.1%
    PRS 29.0%
  • progenitor cell CL0011026
    CSI 1.0
    rCSI 2.0%
    PRS 25.8%
  • mature alpha-beta T cell CL0000791
    CSI 1.0
    rCSI 3.5%
    PRS 26.7%
  • hepatocyte CL0000182
    CSI 1.0
    rCSI 1.7%
    PRS 14.5%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.0
    rCSI 2.7%
    PRS 24.2%
  • primordial germ cell CL0000670
    CSI 1.1
    rCSI 5.2%
    PRS 68.9%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.1
    rCSI 0.9%
    PRS 17.5%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.1
    rCSI 8.8%
    PRS 16.0%
  • T follicular helper cell CL0002038
    CSI 1.1
    rCSI 0.8%
    PRS 25.2%
  • innate lymphoid cell CL0001065
    CSI 1.1
    rCSI 2.3%
    PRS 23.5%
  • retinal ganglion cell CL0000740
    CSI 1.1
    rCSI 2.5%
    PRS 11.2%
  • memory T cell CL0000813
    CSI 1.2
    rCSI 2.3%
    PRS 34.9%
  • megakaryocyte progenitor cell CL0000553
    CSI 1.2
    rCSI 21.4%
    PRS 44.8%
  • cerebellar granule cell CL0001031
    CSI 1.3
    rCSI 1.8%
    PRS 14.2%
  • BEST4+ enteroycte CL4030026
    CSI 1.3
    rCSI 1.6%
    PRS 16.5%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.3
    rCSI 2.3%
    PRS 9.2%
  • direct pathway medium spiny neuron CL4023026
    CSI 1.3
    rCSI 31.1%
    PRS 7.4%
  • IgA plasma cell CL0000987
    CSI 1.4
    rCSI 1.4%
    PRS 28.9%
  • glial cell CL0000125
    CSI 1.4
    rCSI 5.3%
    PRS 15.4%
  • pluripotent stem cell CL0002248
    CSI 1.4
    rCSI 41.8%
    PRS 35.0%
  • megakaryocyte CL0000556
    CSI 1.4
    rCSI 6.1%
    PRS 27.6%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 1.5
    rCSI 2.3%
    PRS 37.1%
  • follicular B cell CL0000843
    CSI 1.5
    rCSI 5.4%
    PRS 53.1%
  • intestinal epithelial cell CL0002563
    CSI 1.5
    rCSI 1.6%
    PRS 16.3%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [SDCBP](/details-gene/6386) (Syndecan Binding Protein) encodes Syntenin-1, a versatile PDZ domain-containing scaffolding protein that plays a crucial role in intracellular signaling, protein trafficking, and cytoskeletal organization. It functions as an adaptor, linking transmembrane proteins, such as syndecans and ephrin receptors, to various downstream signaling cascades and the actin cytoskeleton [Link](https://doi.org/10.1073/pnas.94.25.13683). **Overall**, [SDCBP](/details-gene/6386) shows highly significant expression in [melanocytes](/details-cell/CL0000148), various populations of macrophages and monocytes, and placental trophoblasts, suggesting key roles in pigmentation, innate immunity, and embryonic development. Its function is implicated in diverse biological processes including cell migration, exosome secretion, and the regulation of cell growth. Clinically, it is associated with OMIM entry [602217](https://omim.org/entry/602217). ## Cellular Roles and Expression Landscape The expression profile of [SDCBP](/details-gene/6386) highlights its importance in specific, functionally distinct cell lineages. **Overall**, its most significant expression is observed in [melanocytes](/details-cell/CL0000148) (CSI: 127.07), suggesting a primary role in pigmentation and melanosome biology, a finding supported by proteomic analyses identifying it as a melanosomal protein [Link](https://doi.org/10.1021/pr025562r). A second major functional niche for [SDCBP](/details-gene/6386) is within the myeloid compartment of the innate immune system. It is highly significant in various macrophage populations, including [elicited macrophages](/details-cell/CL0000861), [alveolar macrophages](/details-cell/CL0000583), and placental [Hofbauer cells](/details-cell/CL3000001), as well as in their circulating precursors, such as [CD14-low, CD16-positive monocytes](/details-cell/CL0002396) and [classical monocytes](/details-cell/CL0000860). This pattern points towards a central function in monocyte-macrophage effector activities, such as phagocytosis, migration, and inflammatory signaling. Furthermore, [SDCBP](/details-gene/6386) is prominently expressed in specialized placental cells like [extravillous trophoblasts](/details-cell/CL0008036) and [placental villous trophoblasts](/details-cell/CL2000060), implicating it in the processes of placental development, invasion, and maternal-fetal interface maintenance. Conversely, the gene's significance is consistently low in cells of the nervous system, including [astrocytes of the cerebral cortex](/details-cell/CL0002605) and various cortical neurons, as well as in the lymphoid lineage, such as [alpha-beta T cells](/details-cell/CL0000789). This restricted expression pattern underscores its specialized roles, primarily outside of neuronal signaling and adaptive immunity. ## Pathways and Molecular Function [SDCBP](/details-gene/6386) functions as a key molecular hub, integrating signals from the cell surface to the intracellular machinery. Its molecular function is defined by its ability to bind a wide array of proteins via its two PDZ domains. Key binding partners include syndecans ([GO:0045545](https://www.ebi.ac.uk/QuickGO/term/GO:0045545)), ephrin receptors ([GO:0046875](https://www.ebi.ac.uk/QuickGO/term/GO:0046875)), and frizzled receptors ([GO:0005109](https://www.ebi.ac.uk/QuickGO/term/GO:0005109)), positioning it at the crossroads of multiple signaling pathways [Link](https://doi.org/10.1016/s0896-6273(00)80663-7). This scaffolding activity translates into the regulation of numerous biological processes. Its involvement in [Actin cytoskeleton organization](/details-go/GO:0030036) and its localization to [focal adhesions](/details-go/GO:0005925) and [adherens junctions](/details-go/GO:0005912) are consistent with its role in modulating [positive regulation of cell migration](/details-go/GO:0030335) [Link](https://doi.org/10.1091/mbc.12.2.339). The gene is a critical component of [Intracellular signal transduction](/details-go/GO:0035556), participating in the [Ras protein signal transduction](/details-go/GO:0007265) pathway and the [positive regulation of JNK cascade](/details-go/GO:0046330). Significantly, [SDCBP](/details-gene/6386) is strongly associated with vesicle trafficking, particularly the [positive regulation of exosomal secretion](/details-go/GO:1903543) and [extracellular exosome assembly](/details-go/GO:1903553). This aligns with its localization to [extracellular exosomes](/details-go/GO:0070062) and suggests a mechanism by which it influences cell-cell communication. In the immune context, its participation in the [Neutrophil degranulation](/details-pathway/R-HSA-6798695) pathway is consistent with its high expression in myeloid cells. Moreover, its role in [Eph-ephrin signaling](/details-pathway/R-HSA-2682334) and [Axon guidance](/details-pathway/R-HSA-422475) highlights its developmental functions, despite its low expression in many mature neural cell types. ## Research Directions The unique expression pattern and multifaceted functions of [SDCBP](/details-gene/6386) suggest several avenues for future investigation. Its roles in disparate biological systems, from skin pigmentation to innate immunity, warrant further mechanistic exploration. Based on the available data, several testable hypotheses can be proposed: 1. Given its status as the top expressed gene in [melanocytes](/details-cell/CL0000148) and its localization to [melanosomes](/details-go/GO:0042470), [SDCBP](/details-gene/6386) may function as a critical trafficking protein that regulates the maturation and transport of melanosomes along the actin cytoskeleton for subsequent transfer to keratinocytes. 2. In the context of macrophages, where [SDCBP](/details-gene/6386) is highly expressed, its role in exosome secretion ([GO:1903543](https://www.ebi.ac.uk/QuickGO/term/GO:1903543)) suggests it orchestrates the packaging and release of inflammatory cytokines and other signaling molecules, thereby modulating the local immune microenvironment. 3. The high significance of [SDCBP](/details-gene/6386) in [extravillous trophoblasts](/details-cell/CL0008036), coupled with its known function in promoting cell migration and epithelial-to-mesenchymal transition ([GO:0010718](https://www.ebi.ac.uk/QuickGO/term/GO:0010718)), indicates it is likely a key driver of trophoblast invasion into the uterine wall, a process essential for successful placentation. To test the first hypothesis regarding its role in melanosome biology, a compelling experimental approach would be to utilize a CRISPR-Cas9 system to knock out [SDCBP](/details-gene/6386) in a human melanocyte cell line. The consequences could be assessed by quantifying melanin content, analyzing melanosome morphology and staging via transmission electron microscopy, and tracking melanosome movement using live-cell imaging. A co-culture system with keratinocytes would further allow for the direct measurement of melanosome transfer efficiency in the absence of [SDCBP](/details-gene/6386). Therapeutically, [SDCBP](/details-gene/6386) presents a complex profile. As an intracellular scaffolding protein, it is not an ideal target for monoclonal antibodies. However, its role in promoting cell migration, proliferation, and exosome-mediated communication is frequently co-opted in cancer metastasis. Therefore, [SDCBP](/details-gene/6386) could be a promising target for small molecule inhibitors designed to disrupt its protein-protein interactions via the PDZ domains. Given its links to oncogenic pathways, inhibition would be the therapeutic strategy, particularly in malignancies derived from cells where it is highly expressed, such as melanoma.

Genular Protein ID: 4139229000

Symbol: SDCB1_HUMAN

Name: Syntenin-1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9391086

Title: Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.

PubMed ID: 9391086

DOI: 10.1073/pnas.94.25.13683

PubMed ID: 9511750

Title: Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene.

PubMed ID: 9511750

DOI: 10.1016/s0378-1119(97)00562-3

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16421571

Title: DNA sequence and analysis of human chromosome 8.

PubMed ID: 16421571

DOI: 10.1038/nature04406

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 9883737

Title: PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands.

PubMed ID: 9883737

DOI: 10.1016/s0896-6273(00)80663-7

PubMed ID: 10230395

Title: A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.

PubMed ID: 10230395

DOI: 10.1016/s1097-2765(00)80470-0

PubMed ID: 10770943

Title: Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.

PubMed ID: 10770943

DOI: 10.1074/jbc.m002459200

PubMed ID: 11152476

Title: The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity.

PubMed ID: 11152476

DOI: 10.1074/jbc.m010647200

PubMed ID: 11432873

Title: Schwannomin isoform-1 interacts with syntenin via PDZ domains.

PubMed ID: 11432873

DOI: 10.1074/jbc.m105792200

PubMed ID: 11179419

Title: Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.

PubMed ID: 11179419

DOI: 10.1091/mbc.12.2.339

PubMed ID: 11498591

Title: Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein.

PubMed ID: 11498591

DOI: 10.1126/science.1059157

PubMed ID: 12643545

Title: Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.

PubMed ID: 12643545

DOI: 10.1021/pr025562r

PubMed ID: 17081065

Title: Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

PubMed ID: 17081065

DOI: 10.1021/pr060363j

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 22660413

Title: Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.

PubMed ID: 22660413

DOI: 10.1038/ncb2502

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 26032692

Title: Syntenin and syndecan in the biogenesis of exosomes.

PubMed ID: 26032692

DOI: 10.1111/boc.201500010

PubMed ID: 25219541

Title: Targeting tumor invasion: the roles of MDA-9/Syntenin.

PubMed ID: 25219541

DOI: 10.1517/14728222.2014.959495

PubMed ID: 26539120

Title: Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells.

PubMed ID: 26539120

DOI: 10.3389/fphar.2015.00241

PubMed ID: 25893292

Title: Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization.

PubMed ID: 25893292

DOI: 10.1038/onc.2015.100

PubMed ID: 26291527

Title: MDA-9/syntenin control.

PubMed ID: 26291527

DOI: 10.1002/jcp.25136

PubMed ID: 12679023

Title: PDZ tandem of human syntenin: crystal structure and functional properties.

PubMed ID: 12679023

DOI: 10.1016/s0969-2126(03)00052-2

PubMed ID: 12842047

Title: Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm.

PubMed ID: 12842047

DOI: 10.1016/s0969-2126(03)00125-4

PubMed ID: 15081807

Title: The PDZ2 domain of syntenin at ultra-high resolution: bridging the gap between macromolecular and small molecule crystallography.

PubMed ID: 15081807

DOI: 10.1016/j.jmb.2004.02.057

PubMed ID: 16533050

Title: The binding of the PDZ tandem of syntenin to target proteins.

PubMed ID: 16533050

DOI: 10.1021/bi052225y

PubMed ID: 27386966

Title: Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.

PubMed ID: 27386966

DOI: 10.1038/ncomms12101

Sequence Information:

  • Length: 298
  • Mass: 32444
  • Checksum: 574E1349F86F949F
  • Sequence:
  • MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS 
    LNEEEIRANV AVVSGAPLQG QLVARPSSIN YMVAPVTGND VGIRRAEIKQ GIREVILCKD 
    QDGKIGLRLK SIDNGIFVQL VQANSPASLV GLRFGDQVLQ INGENCAGWS SDKAHKVLKQ 
    AFGEKITMTI RDRPFERTIT MHKDSTGHVG FIFKNGKITS IVKDSSAARN GLLTEHNICE 
    INGQNVIGLK DSQIADILST SGTVVTITIM PAFIFEHIIK RMAPSIMKSL MDHTIPEV

Genular Protein ID: 1783094541

Symbol: B4DHN5_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 16421571

Title: DNA sequence and analysis of human chromosome 8.

PubMed ID: 16421571

DOI: 10.1038/nature04406

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

Sequence Information:

  • Length: 239
  • Mass: 25968
  • Checksum: C8ECBFCEDF02B3A7
  • Sequence:
  • MSLYPSLEDL KVDKVIQAQT AFSANPANPA ILSEASAPIP HDGNLYPRLY PELSQYMGLS 
    LNEEEIRANV AVVSGAPLQG LVQANSPASL VGLRFGDQVL QINGENCAGW SSDKAHKVLK 
    QAFGEKITMT IRDRPFERTI TMHKDSTGHV GFIFKNGKIT SIVKDSSAAR NGLLTEHNIC 
    EINGQNVIGL KDSQIADILS TSGTVVTITI MPAFIFEHII KRMAPSIMKS LMDHTIPEV

Genular Protein ID: 3473848320

Symbol: G5EA09_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 11181995

Title: The sequence of the human genome.

PubMed ID: 11181995

DOI: 10.1126/science.1058040

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 16421571

Title: DNA sequence and analysis of human chromosome 8.

PubMed ID: 16421571

DOI: 10.1038/nature04406

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

Sequence Information:

  • Length: 318
  • Mass: 34819
  • Checksum: DEA5027C28090AFB
  • Sequence:
  • MIKLWTNRDL HIIVMVKNPA KMSLYPSLED LKVDKVIQAQ TAFSANPANP AILSEASAPI 
    PHDGNLYPRL YPELSQYMGL SLNEEEIRAN VAVVSGAPLQ GLVARPSSIN YMVAPVTGND 
    VGIRRAEIKQ GIREVILCKD QDGKIGLRLK SIDNGIFVQL VQANSPASLV GLRFGDQVLQ 
    INGENCAGWS SDKAHKVLKQ AFGEKITMTI RDRPFERTIT MHKDSTGHVG FIFKNGKITS 
    IVKDSSAARN GLLTEHNICE INGQNVIGLK DSQIADILST SGTVVTITIM PAFIFEHIIK 
    RMAPSIMKSL MDHTIPEV